- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ovarian cancer stem cells and targeted therapy ; volume:12 ; number:1 ; day:6 ; month:12 ; year:2019 ; pages:1-11 ; date:12.2019
Journal of ovarian research ; 12, Heft 1 (6.12.2019), 1-11, 12.2019
- Creator
-
Keyvani, Vahideh
Farshchian, Moein
Esmaeili, Seyed-Alireza
Yari, Hadi
Moghbeli, Meysam
Nezhad, Seyed-Reza Kazemi
Abbaszadegan, Mohammad Reza
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-019-0588-z
- URN
-
urn:nbn:de:101:1-2020040222384154310206
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Keyvani, Vahideh
- Farshchian, Moein
- Esmaeili, Seyed-Alireza
- Yari, Hadi
- Moghbeli, Meysam
- Nezhad, Seyed-Reza Kazemi
- Abbaszadegan, Mohammad Reza
- SpringerLink (Online service)
Other Objects (12)
Targeted cancer therapy
Ovarian Cancer Stem Cells
Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer
Intraperitoneal therapy for ovarian cancer
Advances in ovarian cancer therapy
Advances in targeted cancer therapy
Cancer biomarkers for targeted therapy
Targeted therapy in gastric cancer
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Role of MAML1 in targeted therapy against the esophageal cancer stem cells
Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer
Adjuvant therapy of Early Ovarian Cancer
Targeted cancer therapy
Ovarian Cancer Stem Cells
Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer
Intraperitoneal therapy for ovarian cancer
Advances in ovarian cancer therapy
Advances in targeted cancer therapy
Cancer biomarkers for targeted therapy
Targeted therapy in gastric cancer
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Role of MAML1 in targeted therapy against the esophageal cancer stem cells
Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer
Adjuvant therapy of Early Ovarian Cancer
Targeted cancer therapy
Ovarian Cancer Stem Cells
Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer
Intraperitoneal therapy for ovarian cancer
Advances in ovarian cancer therapy
Advances in targeted cancer therapy
Cancer biomarkers for targeted therapy
Targeted therapy in gastric cancer
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Role of MAML1 in targeted therapy against the esophageal cancer stem cells
Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer